Mei Li

Mei Li is a seasoned professional in statistical programming and clinical development, currently serving as the Director of Statistical Programming at TG Therapeutics, Inc. since October 2020. In this role, Mei Li leads programming activities for clinical study reports, regulatory submissions, and manuscripts. Previous experience includes positions as a Statistical Programmer at ImClone Systems and as a Research Scientist in Computation at Eli Lilly and Company, where responsibilities encompassed leading compound activities and collaborating with cross-functional teams. Additionally, Mei Li held the position of Principal Programmer at Novartis Oncology, overseeing submission activities for regulatory authorities and statistical activities for trials and publications.